Apimeds Pharmaceuticals US, Inc

APUSAMEX · Pharmaceutical Preparations

Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

1.51M

on 2026-06-30, from 790K on 2024-12-31 10-Q ↗

Earlier counts are adjusted for the 1-for-10 reverse split; each bar's tip shows the count as filed.

Newest

None

No S-3 or F-3 shelf on file in the last 30 months.

3 of its filings are not read yet.

Warrants

112K

Warrants of every class as tagged in the XBRL facts on 2026-06-30. 10-Q ↗

Cash

0.1 quarters

$278K on 2026-06-30 ÷ $3.3M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised: 6 of its filings are not read yet.

Also on file: up to $120.9M convertible notes agreed 2025-12-01 8-K ↗ · a 1-for-10 reverse split, 2025-12-01 8-K ↗ · a 1-for-10 reverse split, 2026-07-24 8-K ↗